Sei sulla pagina 1di 5

Free Radical Biology & Medicine, Vol. 35, No. 11, pp.

1448 1452, 2003


Copyright 2003 Elsevier Inc.
Printed in the USA. All rights reserved
0891-5849/03/$see front matter

doi:10.1016/j.freeradbiomed.2003.08.001

Original Contribution
EFFECT OF CIGARETTE SMOKE ON ORAL PEROXIDASE ACTIVITY IN
HUMAN SALIVA: ROLE OF HYDROGEN CYANIDE
IFAT KLEIN,* RAFAEL M. NAGLER,*, RUTH TOFFLER,* ALBERT

VAN

DER VLIET,

and

ABRAHAM Z. REZNICK*

*Department of Anatomy and Cell Biology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa,
Israel; Laboratory of Oral Biochemistry, Rambam Medical Center, Haifa, Israel; and Department of Pathology, University of
Vermont, Burlington, VT, USA
(Received 16 May 2003; Revised 12 August 2003; Accepted 14 August 2003)

AbstractPeroxidase activity in human saliva is composed of salivary peroxidase (80%), of salivary glandular origin,
and myeloperoxidase (20%), of leukocyte origin. The term oral peroxidase (OPO) is used here to denote the total
activity of both peroxidase species. Using the 2-nitrobenzoic acid-thiocyanate assay, OPO activity was measured in the
saliva of nonsmokers after exposure to gas-phase cigarette smoke (CS) in an in vitro system using three puffs of CS in
1 h. A marked decrease of 76% of activity was observed following three puffs of CS. In order to elucidate the
mechanism by which CS caused loss of OPO activity, several oxidants and antioxidants were applied to saliva in vitro
in the presence and absence of CS. No protection for CS-induced loss of OPO activity occurred in the presence of
glutathione, N-acetylcysteine, ascorbic acid, or Desferal. Exposure of saliva to purified aldehydes present in CS did not
significantly affect OPO loss of activity. Similarly, ascorbic acid in the presence of FeCl3 and nicotine also had no effect
on OPO activity. Exposure of OPO to cyanate at levels present in CS caused a 6570% loss of OPO activity, which was
reversible after 24 h of dialysis. Moreover, hydroxocobalamin, a known cyanate chelator, could prevent CS- and
potassium cyanide-induced inactivation of OPO by 70 90%. The results show that hydrogen cyanide, known to be
present in microgram amounts per cigarette, is likely to be the species in CS responsible for loss of salivary OPO
activity. The finding of reduced salivary OPO levels after CS exposure may represent a contributory mechanism for
CS-related compromises in antimicrobial defenses in the aerodigestive tract. 2003 Elsevier Inc.
KeywordsCigarette smoke, Hydrogen cyanide, Hydroxocobalamin, Oral peroxidase, Free radicals

INTRODUCTION

MPO, produced mainly by leukocytes, contributes the


remaining 20 40% of OPO activity [3]. SPO has been
shown to decompose the H2O2 produced by oral bacteria,
while the product of SPO activity, hypothiocyanite ion
(OSCN), is instrumental in killing oral bacteria by
inactivating bacterial glycolytic enzymes such as hexokinase, aldolase, and pyruvate kinase [4 7].
In previous studies we showed that exposure of
plasma to CS resulted in protein modifications as measured by increased protein carbonyls [8] and in oxidation
of plasma lipids and antioxidants [9]. The source of the
accumulation of protein carbonyls was attributed mainly
to the volatile aldehydes present in CS [10]. In more
recent studies, we obtained similar results when human
saliva was exposed to CS in vitro [11]. In addition, we
showed that several salivary enzymes such as amylase,
lactate dehydrogenase (LDH), and acid phosphatase
were considerably affected by CS, while CS-based aldehydes, such as acrolein and crotonaldehyde, as well as

Saliva is a unique fluid, as it is the first body fluid to


encounter the exogenous materials, gases, and fluids that
penetrate the human body [1]. Therefore, nature has
endowed saliva with multiple defense systems, the most
important of which are the immunological and antioxidant defense systems. One of the most important components of the salivary antioxidant system, as well as
being an essential ingredient in the antibacterial system,
is the enzyme salivary peroxidase (SPO), which, together
with myeloperoxidase (MPO), comprises oral peroxidase
activity (OPO). SPO, secreted from the major salivary
glands [2], contributes 60 80% of OPO activity, while
Address correspondence to: Abraham Z. Reznick, Department of
Anatomy and Cell Biology, The Bruce Rappaport Faculty of Medicine,
Technion-Israel Institute of Technology, P.O. Box 9649, 31096 Haifa,
Israel; Tel: 972 (4) 829-5388; Fax: 972 (4) 829-5403; E-Mail:
reznick@tx.technion.ac.il.
1448

CS and oral peroxidase activity

oxygen free radicals, were implicated as the causative


agents affecting those enzymes [11,12]. Thiol compounds such as glutathione (GSH), N-acetylcysteine, and
the iron-chelating agent deferoxamine mesylate (Desferal) could provide substantial protection from the CSassociated loss of salivary amylase and LDH activities.
Recently, we showed that exposure of saliva to CS of
one cigarette caused marked decreases of 48% and 68%
of OPO activity in smokers and nonsmokers, respectively, in both in vivo and in vitro studies [13]. In the in
vivo studies, this loss of activity could be reversed within
1 h and returned to presmoking levels. In the in vitro
studies, it could not be reversed, as no new saliva could
be formed [13]. The purpose of the present study was to
elucidate the mechanisms whereby CS constituents
might influence OPO activity.

MATERIALS AND METHODS

Cigarettes
The cigarettes used in this study were popular commercial cigarettes (Time cigarettes; Dubek Ltd., Tel
Aviv, Israel) containing 14 mg of tar and 0.9 mg of
nicotine per cigarette.
Exposure of saliva to CS: in vitro study
In vitro study was carried out using Time cigarettes
combined with a vacuum system, as described previously
[11,12]. Saliva (4 5 ml) from consenting volunteers was
placed in 50 ml flasks with a sidearm to which the
cigarettes were attached. A reproducible vacuum was
created in the flask and, upon opening the vacuum, the
CS of the whole lighted cigarette was drawn into the
flask. Saliva samples for OPO analysis were drawn before smoking (zero time), and cigarettes were smoked at
intervals of 20 min. Saliva samples for OPO analysis
were drawn at 20 min intervals, prior to the next CS
exposure.
Peroxidase activity
OPO activity was measured according to the 2-nitrobenzoic acid-thiocyanate assay [2]. Briefly, in this assay
5,5-dithiobis, 2-nitrobenzoic acid (DTNB) is reduced to
2-nitrobenzoic acid (NBS) by the addition of -mercaptoethanol. The disappearance of 2-nitrobenzoic acid
while reacting with OSCN, the product of OPO, was
monitored at 412 nM at pH 5.6, as described previously
[3]. One unit of enzyme activity was defined as the level
of enzyme activity needed to cleave 1 mol of 2-nitrobenzoic acid/min at 22C using a molar extinction coefficient of 12,800 [2].

1449

Fig. 1. Effect of exposure of saliva in vitro to three puffs of cigarette


smoke over a 1 h period. Each point represents the mean SEM of
four different experiments. OPO oral peroxidase.

Addition of antioxidants, inhibitors, and oxidants


to saliva
The various reagents and materials were added to
saliva usually at zero time prior to the first smoking puff,
at concentrations specified in the figure legends. Usually,
between 50 100 l of saliva was added to 1 ml of NBS
solution and 100 l of 1 mM of H202 solution making a
dilution of the original saliva of 1:121:24. Thus, the
compounds effects on the assay conditions were really
negligible. In addition, in all experiments, a control without the compounds was run with no difference in the
assay conditions.
All chemicals were purchased from Sigma Chemical
Co. (St. Louis, MO, USA), unless otherwise specified.
Statistical analysis
Statistical analysis was performed using unpaired Students t-test. To determine statistical significance, the
ranges, means, SD, and SEM were computed. Results are
reported as mean SD or SEM. Statistical significance
was set at p .05.
RESULTS

Figure 1 shows the loss of OPO activity after exposure of saliva of four volunteers to three puffs of CS over
a 1 h time period. It can be seen that OPO activity was
decreased over time to about 22% of the control. The
initial mean SEM of the four volunteers was 708 52
mU/ml (n 4).
CS contains a number of constituents (e.g., oxidants,
aldehydes, cyanide) that can cause protein modifications
and influence protein enzyme activity. In order to elucidate which constituents could cause loss of OPO activity,
the saliva of several subjects was exposed to CS in the
presence of 1 mM GSH, Desferal, or ascorbic acid.

1450

I. KLEIN et al.

Fig. 2. Effect of antioxidants on oral peroxidase (OPO) activity exposed to cigarette smoke (CS). exposure to CS only;
exposure to CS 1 mM glutathione; exposure to CS 1 mM
Desferal; exposure to CS 1 mM ascorbate (n 3). Each point
represents the mean SD of saliva from three or four subjects.

Fig. 4. Effect of addition of purified aldehydes present in cigarette


smoke on oral peroxidase activity in saliva of four or five subjects.
control, saliva left in air for 3 h; saliva exposed to acetyl
aldehyde; saliva exposed to crotonaldehyde; saliva exposed
to acrolein.

Figure 2 shows that the rate of loss of OPO activity was


uninfluenced by the presence or absence of all these
antioxidants. Oxidizing the saliva of three volunteers
with 100 M FeCl3 and 1 mM ascorbic acid for 1 or 2 h
did not significantly affect OPO activity and even
slightly increased its level after 2 h (Fig. 3). The addition
of the major aldehydes present at concentrations contained in the CS of one cigarette (2 mM acetyl aldehyde,
80 M acrolein, and 20 M crotonaldehyde) likewise
did not influence salivary OPO activity (Fig. 4).
We also decided to examine the possibility that nicotine at a concentration of 0.9 mg might influence OPO
activity (4 ml of saliva was incubated for 40 min). No
effect on OPO activity was observed (Fig. 5). Next, we
evaluated the degree to which CS-related loss of OPO
activity was reversible by dialysis. After dialysis for 18 h
with no exposure to CS, loss of OPO activity was approximately 20% (Fig. 6, column 2), while saliva exposed to CS with no dialysis lost about 68% of its initial

activity (column 3). Importantly, the activity of saliva


exposed to CS and dialyzed for 18 h returned to 94% of
the level of initial OPO activity, showing that the loss of
OPO activity due to CS exposure was reversible by
dialysis.
Cyanide is a known inhibitor of heme peroxidase, and
the presence of hydrogen cyanide has been reported in
CS [14]. The saliva of four volunteers was incubated in
the presence of 150 M potassium cyanide (KCN) and,
as shown in Fig. 7, caused a drastic loss of OPO activity
after only 2 min of KCN incubation (65%, column 3),
which was reversible by dialysis (column 4), strongly
suggesting that KCN is capable of inhibiting salivary
peroxidase activities (Fig. 7).
Figure 8 shows that addition of increasing amounts of
hydroxocobalamin (OH-CO), a known chelator of cyanide, could to a significant extent prevent the CS-associated loss of OPO activity after 60 min of exposure to
CS (three puffs) (columns 4, 5, and 6). Finally, a similar

Fig. 3. Influence of oxidation on oral peroxidase (OPO) activity at


incubation times of 1 and 2 h. Each value represents the mean SD of
three subjects.

Fig. 5. Effect of incubation of 0.9 mg nicotine/4 ml of saliva for 40 min


in the absence of cigarette smoke. Each value represents the mean
SD of five different experiments. OPO oral peroxidase.

CS and oral peroxidase activity

Fig. 6. Effect of cigarette smoke (CS) on oral peroxidase (OPO)


activity after exposure for 1 h and after dialysis for 18 h. Column 1
control OPO activity at zero time; column 2 control OPO activity
after dialysis for 18 h without exposure to CS; column 3 OPO
activity after exposure to CS for 2 h with no dialysis; column 4 OPO
activity of saliva exposed to CS and dialysis for 18 h; column 5
saliva exposed to CS after 18 h without dialysis. Results represent the
mean SD of three different experiments. *p .01; **NS not
significant.

study of exposure of saliva to KCN for 2 min showed


that the addition of OH-CO completely prevented KCNassociated loss of OPO activity (Fig. 9, columns 5 and 6).

1451

Fig. 8. Effect of cigarette smoke (CS) on oral peroxidase (OPO)


activity incubated for 60 min (three puffs) in the absence or presence of
various concentrations of OH-CO. Column 1 control zero time
activity; column 2 control 1 mM OH-CO without exposure to CS;
column 3 saliva CS exposure without addition of OH-CO; column
4 saliva CS 0.5 mM OH-CO; column 5 saliva CS 1 mM
OH-CO (n 3); column 6 saliva CS 2 mM OH-CO. Each
value represents the mean SD of three or four experiments with
saliva of three or four different subjects. *p .01; **p .05 vs. loss
at 60 min.

The major aim of the present study was to try to


understand the underlying causes behind the phenomenon that gas-phase CS can rapidly inactivate a large
percentage of OPO activity in both in vitro and in vivo
systems. Because CS contains an abundance of oxidants,

our initial approach was to determine whether or not CS


oxidants were responsible for the loss of OPO activity.
Ascorbic acid, Desferal, and GSH were shown not to
influence the rate of CS-associated loss of OPO activity
(Figs. 2 and 3). The fact that oxidants in CS were
unlikely to influence loss of OPO activity was buttressed
by the fact that the oxidizing FeCl3/ascorbic acid system
also failed to influence salivary OPO activity (Fig. 3).
A second approach was to try to examine the effect of
known aldehydes present in CS, knowing that reactive
aldehydes are able to influence structure and functions of

Fig. 7. Effect of addition of potassium cyanide (KCN) on oral peroxidase (OPO) activity and recovery after dialysis. Column 1 control
OPO activity at zero time; column 2 control OPO activity after
dialysis for 18 h without exposure to KCN; column 3 OPO activity
after exposure to 150 M KCN for 2 min with no dialysis; column 4
OPO activity of saliva exposed to KCN and dialysis for 18 h; column
5 saliva exposed to KCN after 18 h without dialysis. Results
represent the mean SD of four different experiments. *p .02;
**NS not significant.

Fig. 9. Effect of potassium cyanide (KCN) on oral peroxidase (OPO)


activity incubated for 2 min in the absence or presence of various
concentrations of OH-CO. Column 1 control zero time activity of
OPO; column 2 control 1 mM OH-CO; column 3 saliva 0.5
mM KCN; column 4 saliva 1 mM KCN; column 5 saliva CS
0.5 mM KCN 1 mM OH-CO; column 6 saliva CS 1 mM
KCN 1 mM OH-CO. Each value represents the mean SD of three
or four experiments with saliva of three or four different subjects. *p
.01.

DISCUSSION

1452

I. KLEIN et al.

many proteins. This was attempted in light of previous


studies in which aldehydes were shown to cause accumulation of protein carbonyls in plasma [8] and GSH and
N-acetylcysteine were capable of ameliorating this accumulation in both plasma and salivary proteins [8,11].
However, the results of the current study clearly demonstrated that neither thiols nor exposure to aldehydes
could affect the activity of OPO (Figs. 3 and 4). After
realizing that most common known compounds in CS
that can possibly effect OPO activity failed to do so, we
hypothesized that it could be a small stable molecule that
binds reversibly to OPO active site. Dialysis is one way
to prove this hypothesis because, upon using kinetics of
osmotic concentration where there is no cyanide outside
the dialysis bag, the cyanide inside the bag will move
outside and disturb the equilibrium between bound and
free cyanide, where eventually the bound cyanide will
also dissociate from OPO active site and OPO activity
will be restored.
Thus, using this third approach, investigating whether
loss of OPO activity would be reversible after dialysis,
indicated that indeed a small, stable molecule present in
CS was responsible for the observed effect. Figures 6 and
7 demonstrate that the loss of activity was reversible by
dialysis and that the most potent inhibitor of heme peroxidases, the cyanide ion, was most probably the culprit
underlying this inactivation. As was mentioned in the
introduction, OPO is composed of two distinct enzymes,
SPO and MPO. The fact that KCN did not inhibit OPO
completely may hint that cyanide can influence the two
enzymes differently. However, in a previous publication
[13], it was shown that using a specific inhibitor of SPO,
dapsone, the kinetics of SPO and MPO inactivation by
CS was quite similar, hinting that cyanide inhibits both
peroxidases in a similar way. Nevertheless, one can
assume that there can be other factors that may influence
OPO activity besides cyanide. However, preincubation
of saliva with OH-CO could prevent the CS- and KCNassociated loss of OPO activity, indicating again that
cyanide was most probably responsible for the major loss
of OPO activity. Indeed, it has been reported that hydrogen cyanide is present in 70 350 mol in gas-phase CS
of various cigarette brands [14].
The significance of CS-induced reductions in salivary
peroxidase activities is unknown. Our findings suggest
that it might be one of the mechanisms involved in
CS-related mouth morbidity. Further studies are needed
to elucidate the role of CS-related inhibition of saliva
peroxidase activities in oral pathobiology.
Acknowledgement This work was supported by a grant from the
Technion Vice-President for Research and a grant from the Krol
Foundation of Lakewood, NJ, USA.

REFERENCES
[1] Mandel, I. D. The role of saliva in maintaining oral homeostasis.
J. Am. Dent. Assoc. 119:298 304; 1989.
[2] Nagler, R. M.; Klein, I.; Zarzhevsky, N.; Drigues, N.; Reznick,
A. Z. Characterization of the differentiated antioxidant profile of
human saliva. Free Radic. Biol. Med. 32:268 277; 2002.
[3] Pruitt, K. M.; Kamau, D. N.; Miller, K.; Mansson-Rahemtulla, B.;
Rahemtulla, F. Quantitative, standardized assays for determining
the concentrations of bovine lactoperoxidase, human salivary
peroxidase, and human myeloperoxidase. Anal. Biochem. 191:
278 286; 1990.
[4] Toljanic, J. A.; Siddiqui, A. A.; Patterson, G. L.; Irwin, M. E. An
evaluation of a dentifrice containing salivary peroxidase elements
for the control of gingival disease in patients with irradiated head
and neck cancer. J. Prosthet. Dent. 76:292296; 1996.
[5] Grisham, M. B.; Ryan, E. M. Cytotoxic properties of salivary
oxidants. Am. J. Physiol. Cell Physiol. 258:C115C121; 1990.
[6] Guven, Y.; Satman, I.; Dinccag, N.; Alptekin, S. Salivary peroxidase activity in whole saliva of patients with insulin-dependent
(type-1) diabetes mellitus. J. Clin. Periodontol. 23:879 881;
1996.
[7] Aune, T. M.; Thomas, E. L. Accumulation of hypothiocyanite ion
during peroxidase-catalyzed oxidation of thiocyanate ion. Eur.
J. Biochem. 80:209 214; 1977.
[8] Reznick, A. Z.; Cross, C. E.; Hu, M.-L.; Suzuki, Y. J.; Khwaja, S.;
Safadi, A.; Motchnik, P. A.; Packer, L.; Halliwell, B. Modification of plasma proteins by cigarette smoke as measured by protein
carbonyl formation. Biochem. J. 286:607 611; 1992.
[9] Reznick, A. Z.; Han, D.; Packer, L. Cigarette smoke induced
oxidation of human plasma proteins, lipids, and antioxidants;
selective protection by the biothiols dihydrolipoic acid and glutathione. Redox Rep. 3:169 174; 1997.
[10] ONeill, C. A.; Halliwell, B.; van der Vliet, A.; Davis, P. A.;
Packer, L.; Tritschler, H.; Strohman, W. J.; Rieland, T.; Cross,
C. E.; Reznick, A. Z. Aldehyde-induced protein modifications in
human plasma: protection by glutathione and dihydrolipoic acid.
J. Lab. Clin. Med. 124:359 370; 1994.
[11] Nagler, R.; Lischinsky, S.; Diamond, E.; Drigues, N.; Klein, I.;
Reznick, A. Z. Effect of cigarette smoke on salivary proteins and
enzyme activities. Arch. Biochem. Biophys. 379:229 236; 2000.
[12] Nagler, R. M.; Lischinsky, S.; Diamond, E.; Klein, I.; Reznick,
A. Z. New insights into salivary lactate dehydrogenase of human
subjects. J. Lab. Clin. Med. 137:363369; 2001.
[13] Reznick, A. Z.; Klein, I.; Eiserich, J. P.; Cross, C. E.; Nagler,
R. M. Inhibition of oral peroxidase activity by cigarette smoke: in
vivo and in vitro studies. Free Radic. Biol. Med. 34:377384;
2003.
[14] Fowles, J.; Bates, M. The chemical constituents in cigarettes and
cigarette smoke: priorities for harm reduction. A report to the
New Zealand Ministry of Health; March, 2000:16.

ABBREVIATIONS

CN cyanide
CS cigarette smoke
GSH glutathione
KCNpotassium cyanide
LDHlactate dehydrogenase
MPOmyeloperoxidase
OH-CO hydroxocobalamin
OPO oral peroxidase
OSCN hypothiocyanite ion
SPOsalivary peroxidase

Potrebbero piacerti anche